Development of therapeutics for biodefense

  • Description
  • Details
  • Subprojects
  • History
  • Relations
  • Publications
Project Title: Development of therapeutics for biodefense
Project Number: 272201100029C-2-0-1
Project web address: Follow on NIH
Organization: Enanta Pharmaceuticals, Inc., United States, Massachusetts, WATERTOWN
Principal Investigators (PI): Or Yat Sun, US
 
Project Description:
This contract supports the advanced development of promising biodefense therapeutic candidates/products with broad spectrum activity. The research and development activities supported will allow candidate therapeutic countermeasures to progress through the product development pipeline, and includes preclinical/non-clinical and clinical IND development activities.
 
Project Terms:
advanced development anti-bacterial agents antimicrobial resistance biodefense clinical development gram-positive bacteria pre-clinical product development research and development support contracts therapeutic therapeutic development emerging infectious diseases infectious diseases
Project Title: Development of therapeutics for biodefense
Project Number: 272201100029C-2-0-1
Project web address: Follow on NIH
Organization: Enanta Pharmaceuticals, Inc., United States, Massachusetts, WATERTOWN
Principal Investigators (PI): Or Yat Sun, US
 
Project Categories:
Infrastructure & Equipment
 
Other Information:
Fiscal Year: 2011
Project Start Date: 27 September 2011
Project End Date: 28 February 2015
 
Project Funding Information:
Funding Mechanism: Non SBIR/STTR Contracts
Year Funding Organization Total Funding, $
2013 NIH - National Institute Of Allergy And Infectious Diseases $9,218,951
Project Title: Development of therapeutics for biodefense
Project Number: 272201100029C-2-0-1
Project web address: Follow on NIH
Organization: Enanta Pharmaceuticals, Inc., United States, Massachusetts, WATERTOWN
Principal Investigators (PI): Or Yat Sun, US
 
Title FY Funding
There are no results for this project in database.
Project Title: Development of therapeutics for biodefense
Project Number: 272201100029C-2-0-1
Project web address: Follow on NIH
Organization: Enanta Pharmaceuticals, Inc., United States, Massachusetts, WATERTOWN
Principal Investigators (PI): Or Yat Sun, US
 
Project Title Organization FY Funding
Development Of Therapeutics For BiodefenseEnanta Pharmaceuticals, Inc.2013$9,218,951
Project Title: Development of therapeutics for biodefense
Project Number: 272201100029C-2-0-1
Project web address: Follow on NIH
Organization: Enanta Pharmaceuticals, Inc., United States, Massachusetts, WATERTOWN
Principal Investigators (PI): Or Yat Sun, US
 
Project number Project title Principal investigator
There are no any related projects.
Project Title: Development of therapeutics for biodefense
Project Number: 272201100029C-2-0-1
Project web address: Follow on NIH
Organization: Enanta Pharmaceuticals, Inc., United States, Massachusetts, WATERTOWN
Principal Investigators (PI): Or Yat Sun, US
 
Title Journal Year Country Rel